Our Dallas healthcare lawyers handle a wide range of matters and disputes:
Healthcare and Partnership Lawyers
Partnership models, private-equity roll-ups, and aggressive practice acquisitions are redrawing the healthcare map in Texas, but every consolidation, joint venture, or physician employment deal carries heavy legal risk. From shareholder deadlock and MSO governance disputes to Stark-Law compliance, Anti-Kickback enforcement, and noncompete battles, a single misstep can freeze capital, upend revenue cycles, and jeopardize patient care.
Add construction delays on new facilities, bond-financed expansion projects, and high-stakes commercial litigation with vendors, and it’s clear that healthcare organizations face a constant, multifront legal threat.
Roquemore Skierski’s Dallas-based healthcare lawyers counsel hospitals, ASC operators, physician groups, management service organizations, and private-equity–backed roll-ups across the state. We pair transaction fluency—structuring mergers, acquisitions, JV operating agreements, and complex capital–finance deals—with courtroom strength in partnership disputes, corporate governance litigation, and physician-contract enforcement.
Our focus is relentlessly commercial: every strategy is calibrated to protect enterprise value, preserve referral networks, and keep regulators satisfied while your clinicians remain focused on patient outcomes.
Add construction delays on new facilities, bond-financed expansion projects, and high-stakes commercial litigation with vendors, and it’s clear that healthcare organizations face a constant, multifront legal threat.
Roquemore Skierski’s Dallas-based healthcare lawyers counsel hospitals, ASC operators, physician groups, management service organizations, and private-equity–backed roll-ups across the state. We pair transaction fluency—structuring mergers, acquisitions, JV operating agreements, and complex capital–finance deals—with courtroom strength in partnership disputes, corporate governance litigation, and physician-contract enforcement.
Our focus is relentlessly commercial: every strategy is calibrated to protect enterprise value, preserve referral networks, and keep regulators satisfied while your clinicians remain focused on patient outcomes.